-
1 Comment
Morishita Jintan Co., Ltd is currently in a long term downtrend where the price is trading 1.9% below its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Morishita Jintan Co., Ltd's total revenue sank by 1.7% to $2B since the same quarter in the previous year.
Its net income has dropped by 79.8% to $20M since the same quarter in the previous year.
Based on the above factors, Morishita Jintan Co., Ltd gets an overall score of 1/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Exchange | TSE |
| CurrencyCode | JPY |
| Sector | Healthcare |
| ISIN | JP3924400009 |
| PE Ratio | 15.87 |
|---|---|
| Target Price | None |
| Market Cap | 9B |
| Dividend Yield | 2.6% |
| Beta | -0.1 |
Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health foods in Japan. The company offers health food products, oral care product, and medical supplies under the JINTAN brand. It also sells health food, medicines, food, and miscellaneous goods, as well as other company's products through phone/postcard/online shop; domestic products through department stores, drugstores, convenience stores, volume sellers, and supermarkets; and BabyD 200 and Bifidobacterium Pearl products through medical institutions. In addition, the company offers OEM contract services. Further, it develops Jintan capsule technology that allows encapsulating various contents, such as powder, liquid, microbe or others. Morishita Jintan Co., Ltd. was founded in 1893 and is headquartered in Chuo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4524.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
